Radiopharmaceutical diagnostics and therapeutics across oncology, neurology, cardiology
Lantheus manufactures radiopharmaceuticals for precision diagnostics and targeted cancer therapeutics. The company is mid-stage in a finance-systems overhaul—adopting SAP FICO, SAP Analytics Cloud, and Microsoft Purview while operationalizing SAP S/4HANA—driven by internal pain points around audit efficiency, reimbursement complexity, and incentive-compensation accuracy. Hiring leans heavily toward senior and director roles in healthcare, sales, and quality, suggesting both scaling of commercial operations and execution of manufacturing/regulatory improvements.
Notable leadership hires: Incentive Compensation Associate Director, Asset Lead
Lantheus is a public-company radiopharmaceutical manufacturer focused on precision diagnostics and targeted therapeutics in oncology, neurology, and cardiology. Founded in 1956 and headquartered in Bedford, Massachusetts, the company operates manufacturing and commercial offices across North America and Europe. The product portfolio centers on radiopharmaceuticals—imaging agents and therapeutic compounds—sold into hospital networks and imaging centers. Current project work spans supply-chain optimization (SAP EWM warehouse configuration, dangerous-goods compliance), reimbursement and patient-referral workflows, and finance process improvement (FICO, real-time reconciliation, FP&A automation).
SAP suite (S/4HANA, EWM, Transportation Management, FICO, Analytics Cloud), Veeva PromoMats, Palo Alto Networks, Zscaler, Azure, AWS, Nutanix, VMware, and Johnson Controls Metasys. Currently adopting Microsoft Purview for data governance.
SAP S/4HANA (live), SAP EWM (warehouse configuration in progress), SAP FICO (active implementation), SAP Analytics Cloud (adopting), SAP Real-Time Reconciliation (RTR solution implementation), and Ariba for procurement.
Other companies in the same industry, closest in size